Caroline Stout
Chief Investment Officer bei PANACEA ACQUISITION CORP. II
Ursprung des Netzwerks ersten Grades von Caroline Stout
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Georgetown University
285
| College/University | Other Consumer Services | 285 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA.
17
| Holding Company | Biotechnology | 17 |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY.
11
| Subsidiary | Biotechnology | 11 |
| Private Company | Financial Conglomerates | 8 | |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients.
7
| Private Company | Investment Managers | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Caroline Stout
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Corporate Officer/Principal Trading-Fixed Income Analyst-Equity | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Analyst-Equity | |
| AKOUOS | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity Analyst-Equity | |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Founder Founder | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment ManagersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Investment Managers | Analyst-Equity Analyst-Equity | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | President Director/Board Member | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Fixed Income Analyst-Equity | |
| Saïd Business School | College/University | Masters Business Admin Masters Business Admin | |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Investment Banks/Brokers | Analyst-Equity Analyst-Fixed Income | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| McDonough School of Business | College/University | Undergraduate Degree Undergraduate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Georgetown University Law Center | College/University | Graduate Degree Doctorate Degree | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| United States Naval Academy | College/University | Undergraduate Degree Undergraduate Degree | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Private Equity Investor Director/Board Member | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
| Brown University | College/University | Graduate Degree Undergraduate Degree | |
T. Rowe Price Associates, Inc. (Investment Management)
 T. Rowe Price Associates, Inc. (Investment Management) Investment ManagersFinance T. Rowe Price Associates, Inc. (Price Associates) is a registered investment advisor and mutual fund manager headquartered in Baltimore, Maryland. The firm was founded by Thomas Rowe Price, Jr. in 1937. They are a subsidiary of the T. Rowe Price Group, Inc. (NASDAQ: TROW), which was formed in 2000 as the publicly traded parent holding company of Price Associates and their affiliated entities. Price Associates offers a variety of mutual funds, sub-advisory services and separate account management for individual and institutional investors, retirement plans and financial intermediaries. | Investment Managers | Analyst-Equity Analyst-Equity | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
LifeStance Health, Inc.
 LifeStance Health, Inc. Medical/Nursing ServicesHealth Services LifeStance Health, Inc. is a behavioral healthcare company, which engages in the provision of healthcare and treatment services for children, adolescents, and adults suffering from mental health issues. Its services include intensive outpatient therapy; neuropsychological testing; individual therapy, group therapy; independent medical examination; and cognitive behavioral therapy. The company was founded by Michael K. Lester in 2017 and is headquartered in Bellevue, WA. | Medical/Nursing Services | Director/Board Member | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Kite Pharma EU BV
 Kite Pharma EU BV BiotechnologyHealth Technology Part of Gilead Sciences, Inc., Kite Pharma EU BV is a Dutch company dedicated to curing cancer. The company is based in Harlem, the Netherlands. The company specializes in cell therapy and immuno-oncology therapies that have the potential to transform the way cancer is treated. Kite Pharma was acquired by Kite Pharma, Inc., part of Gilead Sciences, Inc. from October 04, 2017 on March 17, 2015 for $275.56 million. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BofA Securities, Inc.
 BofA Securities, Inc. Investment Banks/BrokersFinance BofA Securities, Inc. is a registered broker-dealer subsidiary of NB Holdings Corp., ultimately held by Bank of America Corp. (NYSE: BAC). Headquartered in New York, the firm was founded in 2015 and offers trade execution, trading or brokerage services to institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
| Vanderbilt University | College/University | Corporate Officer/Principal | |
Healthcare Private Equity Association
 Healthcare Private Equity Association Financial ConglomeratesFinance The Healthcare Private Equity Association is a non-profit trade association that supports the reputation, knowledge, and relationships of the healthcare private equity community. The non-profit company is based in Needham, MA. The association's member firms are committed to building successful and enduring businesses in the healthcare industry. The company brings industry knowledge, broad networks, and deep expertise to help companies grow, create jobs, and deliver high-quality healthcare. The association's member firms have over $1 trillion in assets under management and have supported the growth of over 1500 healthcare businesses. The company was founded by Jeffrey K. Rhodes, Brian Christopher Miller. | Financial Conglomerates | Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| CONVEY HEALTH SOLUTIONS HOLDINGS, INC. | Packaged Software | Director/Board Member | |
Insignia Capital Group LLC
 Insignia Capital Group LLC Investment ManagersFinance Insignia Capital Group LLC (Insignia Capital Group) is a private equity firm founded in 2011 by David L. Lowe, Tony Broglio and Mel E. Deane. The firm is headquartered in Walnut Creek, California. | Investment Managers | Director/Board Member | |
Convey Health Solutions, Inc.
 Convey Health Solutions, Inc. Packaged SoftwareTechnology Services Convey Health Solutions, Inc. provides healthcare technology and business process outsourcing services. The firm offers inbound member services, telephonic licensed enrollment, click-to-chat services, and enrollment processing. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL. | Packaged Software | Director/Board Member | |
Ellodi Pharmaceuticals
 Ellodi Pharmaceuticals BiotechnologyHealth Technology Ellodi Pharmaceuticals engages in the provision of pharmaceutical services. It is dedicated to the clinical development of APT-1011, a novel therapy in Phase 3 development for the treatment of Eosinophilic Esophagitis (EoE) spun-out of Adare Pharmaceuticals (Adare). The company is headquartered in the United States. | Biotechnology | Director/Board Member | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 3 |
| Frankreich | 2 |
| Niederlande | 2 |
Sektoral
| Finance | 19 |
| Health Technology | 17 |
| Consumer Services | 13 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 295 |
| Corporate Officer/Principal | 132 |
| Undergraduate Degree | 89 |
| Independent Dir/Board Member | 59 |
| Private Equity Investor | 54 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nina Kjellson | 49 |
| Ed Mathers Mathers | 47 |
| Martin Murphy | 33 |
| Joe Amato | 28 |
| Gonçalo João Figueira Morais Soares | 26 |
| Douglas Williams | 25 |
| David Tanen | 25 |
| Dave Grayzel | 23 |
| Douglas Giordano | 22 |
| Charles Sigal | 20 |
| Sean Nolan | 18 |
| Oleg Nodelman | 15 |
| Katherine Wood | 14 |
| Fernando Bunker Gentil | 13 |
| Ira Shoulson | 11 |
- Börse
- Insiders
- Caroline Stout
- Unternehmensverbindungen
